A dual mode targeting probe for distinguishing HER2-positive breast cancer cells using silica-coated fluorescent magnetic nanoparticles

Journal of Nanoparticle Research

Volumn 15, Issue 10, 2013, Pages

  Li, Jia ^a   An, Yan Li ^a   Zang, Feng Chao ^a   Zong, Shen Fei ^a   Cui, Yi Ping ^a   Teng, Gao Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Breast cancer targeting; Dual mode nanoprobe; Fluorescence; HER2; Magnetic resonance imaging

Indexed keywords

CELL CULTURE; DIAGNOSIS; DISEASES; FLUORESCENCE; FLUORESCENCE IMAGING; IRON OXIDES; MAGNETIC NANOPARTICLES; MAGNETIC RESONANCE IMAGING; MAGNETISM; MAGNETITE; MEDICAL IMAGING; NANOPROBES; PROBES; SILICA;

BREAST CANCER; BREAST CANCER CELLS; CANCER CELL LINES; CORE SHELL STRUCTURE; DUAL MODES; EXPRESSION LEVELS; HER2; HUMAN BREAST CANCER CELLS;

CELLS;

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT MAGNETIC NANOPARTICLE; IRON OXIDE; MAGNETIC NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOPROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

EID: 84887001210     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1980-z     Document Type: Article

References (30)

1. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD (2009) Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 5:701-708
2. Au L, Zhang Q, Cobley CM, Gidding M, Schwartz AG, Chen J et al (2010) Quantifying the cellular uptake of antibody-conjugated au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 4:35-42
3. Burks SR, Barth ED, Halpern HJ, Rosen GM, Kao JPY (2009) Cellular uptake of electron paramagnetic resonance imaging probes through endocytosis of liposomes. Biochim Biophys Acta 1788:2301-2308
4. Burks SR, Macedo LF, Barth ED, Tkaczuk KH, Martin SS, Rosen GM, Halpern HJ, Brodie AM, Kao JPY (2010) Anti-HER2 Immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells. Breast Cancer Res Treat 124:121-131
5. Burks SR, Legenzov EA, Rosen GM, Kao JPY (2011) Clearance and biodistribution of liposomally-encapsulated nitroxides: a model for targeted delivery of electron paramagnetic imaging probes to tumors. Drug Metab Dispos 39:1961-1966
6. Chan WCW, Nie SM (1998) Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281:2016-2018 (Pubitemid 28475486)
7. Cho H-S, Dong Z, Pauletti GM, Zhang J, Xu H, Gu H et al (2010) Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. ACS Nano 4:5398-5404
8. Chou S-W, Shau Y-H, Wu P-C, Yang Y-S, Shieh D-B, Chen C-C (2010) In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc 132:13270-13278
9. Cui Y, Zheng X-S, Ren B, Wang R, Zhang J, Xia N-S et al (2011) Au@organosilica multifunctional nanoparticles for the multimodal imaging. Chem Sci 2:1463-1469
10. Das M, Mishra D, Dhak P, Gupta S, Maiti TK, Basak A et al (2009) Biofunctionalized phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging. Small 5:2883-2893
11. Gao J, Liang G, Cheung JS, Pan Y, Kuang Y, Zhao F et al (2008) Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. J Am Chem Soc 130:11828-11833
12. Guillemard V, Nedev HN, Berezov A, Murali R, Saragovi HU (2005) HER2-Mediated internalization of a targeted prodrug cytotoxic conjugate is dependent on the valency of the targeting ligand. DNA Cell Biol 24:350-358 (Pubitemid 40840343)
13. He H, Li Y, Jia X-R, Du J, Ying X, Lu W-L et al (2011) PEGylated Poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials 32:478-487
14. Hong X, Wang Z, Yang J, Zheng Q, Zong S, Sheng Y et al (2012) Silylated BODIPY dyes and their use in dye-encapsulated silica nanoparticles with switchable emitting wavelengths for cellular imaging. Analyst 137:4140-4149
15. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G et al (2012) Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One 7:e31422
16. Lee C-H, Cheng S-H, Wang Y, Chen Y-C, Chen N-T, Souris J et al (2009) Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv Funct Mater 19:215-222
17. Lu Y, Yin YD, Mayers BT, Xia YN (2002) Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett 2:183-186 (Pubitemid 135706288)
18. Miyano T, Wijagkanalan W, Kawakami S, Yamashita F, Hashida M (2010) Anionic amino acid dendrimer-trastuzumab conjugates for specific internalization in her2-positive cancer cells. Mol Pharm 7:1318-1327
19. Nam SH, Bae YM, Park YI, Kim JH, Kim HM, Choi JS et al (2011) Long-term real-time tracking of lanthanide ion doped upconverting nanoparticles in living cells. Angew Chem Int Ed 50:6093-6097
20. Qiu Y, Liu Y, Wang L, Xu L, Bai R, Ji Y et al (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31:7606-7619
21. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H (2009) Nanomedicine-challenge and perspectives. Angew Chem Int Ed 48:872-897
22. Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C et al (2009) Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3:197-206
23. Soenen SJ, Rivera-Gil P, Montenegro J-M, Parak WJ, De Smedt SC, Braeckmans K (2011) Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6:446-465
24. von Maltzahn G, Centrone A, Park J-H, Ramanathan R, Sailor MJ, Hatton TA et al (2009) SERS-coded gold nanorods as a multifunctional platform for densely multiplexed near-infrared imaging and photothermal heating. Adv Mater 21:3175-3180
25. Wang Z, Zong S, Yang J, Li J, Cui Y (2011) Dual-mode probe based on mesoporous silica coated gold nanorods for targeting cancer cells. Biosens Bioelectron 26:2883-2889
26. Wartlick H, Michaelis K, Balthasar S, Strebhardt K, Kreuter J, Langer K (2004) Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells. J Drug Targeting 12:461-471 (Pubitemid 39562430)
27. Xiao Y, Gao X, Maragh S, Telford WG, Tona A (2009) Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer. Clin Chem 55:1307-1315
28. Yamauchi H, Stearns V, Hayes DF (2001) When is a tumor marker ready for prime time? a case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol 19:2334-2356 (Pubitemid 32366985)
29. Yang D, Hu J, Fu S (2009) Controlled synthesis of magnetite-silica nanocomposites via a seeded sol-gel approach. J Phys Chem C 113:7646-7651
30. Yang J, Wang Z, Zong S, Song C, Zhang R, Cui Y (2012) Distinguishing breast cancer cells using surface-enhanced Raman scattering. Anal Bioanal Chem 402:1093-1100